Sector check · Biotech
Biotech Stocks: Where Does the Sector Stand?
Data as of November 19, 2026 · updated 4× a day
Biotech companies develop drugs based on biological processes — their value depends on clinical trial results and approvals. No sector produces explosive single-stock moves more often: trial data or takeovers can multiply or halve a stock overnight. FyndStock measures sector strength four times a day across all US biotech stocks in the universe.
Biotech is the sector of binary events: one trial readout, one approval decision or one takeover offer — and the stock is 40% higher or lower before any stop loss could kick in. That's why biotech is both the favorite hunting ground of episodic pivot traders and a minefield for anyone who ignores position sizing. This page shows live how strong the sector is right now.
How strong is the sector right now?
Stocks in the scan
14
Avg momentum
50 / market 38
Confirmed setups
2
Industry rank
#2 of 10
The sector currently shows above-average momentum. 2 stocks currently meet the criteria of several strategies at once. Rank = average momentum compared with the major industries in the universe.
The strongest Biotech stocks by momentum
Sorted by momentum score (0–100) · Trend = Trend Template criteria met
Members see in the screener which stocks are confirmed by several strategies at once (Confluence).
What makes biotech stocks different?
A company's value often depends on a handful of drug candidates in clinical trials. Positive Phase 3 data or an FDA approval can trigger a revaluation within hours; a failure wipes out years of priced-in hope. Add permanent takeover speculation: big pharma regularly buys successful developers — at premiums of 50% or more.
In the FyndStock universe (large and mid caps), biotech is represented by about a dozen established names — extreme micro caps with a single drug candidate are deliberately not part of the scan.
Why do momentum traders love the sector — and fear it?
Biotech produces the setups Kristjan Kullamägi (Qullamaggie) calls "episodic pivots": a catalyst sends the stock sharply higher on huge volume, and the revaluation often carries for months. On the other side is gap risk: the big moves happen overnight, outside trading hours — the stop loss then doesn't protect you at the price you set, only at the next open.
The consequence isn't a ban list, it's math: smaller position sizes than usual, so that even an extreme scenario only scratches the account instead of wounding it.
How do you trade biotech with momentum strategies?
The screener treats biotech like any other stock — trend structure, relative strength, volume. What you should check in addition: is a known catalyst coming up (trial data, an FDA date)? Treat those dates like earnings — known binary events before which you either reduce the position or hold it deliberately. Overall biotech strength is also a good indicator of the broader market's appetite for risk.
Biotech stocks FAQ
What is the difference between biotech and pharma?+
Pharma companies have broad product portfolios, stable revenue and dividends. Biotechs are focused developers whose value depends on a few pipeline candidates — much more volatile, with bigger opportunities and risks.
Why do biotech stocks jump so much?+
Because clinical trials and approvals are binary events: success or failure, with little in between. The market prices in probabilities — the result replaces probability with certainty overnight.
What is an episodic pivot?+
A setup described by Kristjan Kullamägi (Qullamaggie): a fundamental catalyst (trial data, approval, takeover) triggers a price jump on extreme volume and often starts a revaluation lasting months. Biotech is the classic sector for it.
Does a stop loss protect you in biotech stocks?+
Only to a limited extent: the big moves happen overnight as gaps — the order is filled at the next open, not at the stop level. That makes position size the more important risk tool in biotech.
How does FyndStock measure the strength of the biotech sector?+
With the average momentum of all biotech stocks compared to the whole universe and the number of confirmed setups (ELITE/STRONG/GOOD) — recalculated four times a day.
How do I find the strongest biotech stock right now?+
The momentum ranking on this page shows the strongest stocks, updated daily. The full analysis is in the screener — the Minervini strategy is free forever.
Find Biotech setups automatically
FyndStock scans more than 900 US stocks four times a day with 5 Champion strategies — including a Confluence rating that shows which Biotech stocks are confirmed by several strategies at once.
See all of today's confirmed setupsKeep reading
More sectors in the momentum check
Data as of November 19, 2026. This page is for educational and informational purposes only and is not investment advice or a recommendation to buy or sell. The ranking is based on technical metrics, not on an assessment of the companies. Trading securities involves substantial risk, including the loss of your entire investment. Past metrics are not a reliable indicator of future performance.